Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Acute lymphocytic leukemia (ALL) in the elderly is not common, but as in younger adults, a subset will be Philadelphia chromosome postitive (Ph+). In young patients with Ph+ ALL, the addition of imatinib has been shown to be effective in enhancing complete response rates and relapse-free survival.

Imatinib Improves Outcomes in Elderly Patients with Ph+ ALL